Would assume the one this afternoon at 9 3p is too
The Company announces that Emma Rockey, Group Financial Controller and Company Secretary of Corero, has purchased 79,660 Ordinary Shares. Following this purchase, Emma Rockey has a total beneficial interest in 79,660 Ordinary Shares equivalent to 0.016% per cent. of the Company's issued share capital.
We're thrilled that like us, the EMA has recognised the promise of this potential breakthrough medicine. We will now submit an application for US FDA orphan drug designation and continue discussions with potential future licensing partners and will provide further updates in due course as appropriate."
As at 30 June 2025, £9.8m had been drawn down (31 December 2024: £4.9m), with further drawdowns planned during H2 2025. The balance of the loan facility is expected to be fully invested by the end of 2025.
In the event that any of these payments is not made by the due date POW reserves the right to cancel the agreement, whereupon all outstanding amounts will be immediately due and payable, and in those circumstances POW will have the right to take enforcement action including presentation of a winding up petition following the making of a statutory demand in the above amount of approximately £654k.